Patients self assessment of their congestive heart failure.
Minnesota living with heart failure questionnaire mlhfq pdf.
Easy to administer short and easily understood.
Am heart j 1992 124 1017 1025 pubmed abstract rector ts kubo sh cohn jn.
Half of the 21 item minnesota living with heart failure questionnaire mlhfq response categories are labeled 0 no 1 very little 5 very much and half are not 2 3 and 4.
The minnesota living with heart failure questionnaire mlhfq has been developed to measure health related quality of life hrqol status of heart failure hf patients.
The united states food and drug administration fda has approved the minnesota living with heart failure questionnaire as medical device development tool mddt for use in controlled clinical trials designed to test.
The minnesota living with heart failure questionnaire mlhfq is a 21 item paper self administered questionnaire designed as a measure of heart failure as indicated by its adverse effects on.
It provides scores for two dimensions physical and emotional and a total score.
Minnesota living with heart failure questionnaire mlhfq 10 11 13 which has been translated and culturally adapted into at least 34 languages and has demonstrated good psychometric properties in numerous studies 2 5 7 11 14 20.
The university of.
However there are some concerns about its factor structure and alternatives have been proposed some including a third factor.
Content reliability and validity of a new measure the minnesota living with heart failure questionnaire.
However there are some concerns about its factor structure and the homogeneity of items 7 10 13 17.
11 10 04 minnesota living with heart failure questionnaire the following questions ask how much your heart failure heart condition affected your life during the past month 4 weeks.
The united states food drug administration fda has approved the minnesota living with heart failure questionnaire mlhfq as a medical device development tool mddt for use in controlled clinical trials designed to test superiority or non inferiority of medical devices in support of regulatory submissions.